TLR9 does not colocalize with known PLT α granule, dense
granule, lysosomal, or endosomal markers. Washed human
whole-blood PLTs were spun down onto
poly-l-lysine–coated glass cover slides, permeabilized
with 0.5% Triton X-100 for 5 min, and probed for TLR9. (A) PLTs were
colabeled for α granule (fibrinogen, CD62P, PDGF-B, VEGF, CD42a,
and CD42b), dense granule (serotonin), lysosome (LAMP-1), or endosome
(M6P and syntaxin-13) protein markers using two separate colors. Insets
represent magnified regions outlined by the yellow boxes for each image.
(B) TLR9 labeling of whole-blood PLTs from patients with Gray PLT and
Hermansky–Pudlack syndromes was compared with human normal PLT
controls. All samples were examined by wide-field fluorescence
microscopy. (C) 2D intensity scatter plot analysis of image overlays
reveal that, although TLR9 colocalizes well with PDI, it does not
colocalize with either TLR7 or TLR8. These data suggest that TLR9 and
PDI may be distributing to a unique intracellular body (T granule)
underlying the plasma membrane in resting human PLTs. (insets) Bars, 2
µm.